Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Method for detecting pazopanib drug concentration in human plasma by LC-MS/MS (liquid chromatography-mass spectrometry/mass spectrometry)

A technology of pazopanib and drug concentration, applied in the field of drug concentration analysis, to achieve the effects of small introduction error, good separation effect, and improved precision and accuracy

Inactive Publication Date: 2021-01-29
TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] However, the above detection involves mouse plasma, which is different from human plasma. Therefore, it is urgent to develop a rapid, sensitive and accurate detection method for pazopanib in human plasma.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for detecting pazopanib drug concentration in human plasma by LC-MS/MS (liquid chromatography-mass spectrometry/mass spectrometry)
  • Method for detecting pazopanib drug concentration in human plasma by LC-MS/MS (liquid chromatography-mass spectrometry/mass spectrometry)
  • Method for detecting pazopanib drug concentration in human plasma by LC-MS/MS (liquid chromatography-mass spectrometry/mass spectrometry)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0037]In order to solve the technical problem that the prior art does not involve the detection of the drug concentration of pazopanib in human plasma, the present invention provides a LC-MS / MS combined method for detecting the drug concentration of pazopanib in human plasma. The detection method includes taking a series of pazopanib working solutions and mixing them with human blank plasma respectively, injecting them into LC-MS / MS for analysis after pretreatment, and adding a compound mainly composed of pazopanib-d6 to the human plasma to be tested. After pretreatment, the internal standard working solution was also injected into LC-MS / MS for analysis, with the chromatographic peak area ratio of pazopanib and internal standard pazopanib-d6 as the ordinate, and the ratio of pazopanib in human blank plasma The concentration of pazopanib is the abscissa to make a standard curve, and the concentration of pazopanib in the human plasma sample to be tested is calculated according to...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention discloses a method for detecting the drug concentration of pazopanib in human plasma through LC-MS / MS combination, and belongs to the technical field of drug concentration analysis. Themethod comprises the following steps: respectively mixing a series of pazopanib working solutions with human blank plasma, performing pre-treating, injecting the mixture into LC-MS / MS for analysis, adding an internal standard working solution mainly prepared from pazopanib-d6 into human plasma to be detected, performing pre-treating, injecting the mixture into LC-MS / MS for analysis, drawing a standard curve by taking the chromatographic peak area ratio of pazopanib to internal standard pazopanib-d6 as an ordinate and the concentration of pazopanib in human blank plasma as an abscissa, and calculating the concentration of pazopanib in the human plasma sample to be detected according to the standard curve, wherein a protein precipitation method is adopted to pretreat a human plasma sample, an electrospray ion source is adopted as an ionization technology, and the detection method is simple and convenient to operate, high in sensitivity, good in reproducibility, high in selectivity, shortin analysis time and suitable for large-batch detection of clinical samples.

Description

technical field [0001] The invention relates to a method for detecting drug concentration, and belongs to the technical field of drug concentration analysis, in particular to a method for detecting the drug concentration of pazopanib in human plasma by combining LC-MS / MS. Background technique [0002] Renal cell carcinoma (RCC) is one of the most common malignant tumors of the urinary system, accounting for more than 80% of renal malignant tumors. The onset of RCC is hidden, and more than 30% of patients have been diagnosed with metastasis, and RCC is not sensitive enough to radiotherapy and chemotherapy. In the past 10 years, with the development of targeted drugs, the treatment of metastatic RCC has entered the era of targeted therapy. [0003] Pazopanib hydrochloride was developed by GlaxoSmithKline and was approved by the U.S. Food and Drug Administration (FDA) in October 2009 for listing in the U.S. under the trade name Votrient for the treatment of advanced renal cell...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N30/02G01N30/06G01N30/24G01N30/34G01N30/36G01N30/72G01N30/86G01N30/88
CPCG01N30/02G01N30/06G01N30/34G01N30/36G01N30/24G01N30/7266G01N30/8679G01N30/88G01N2030/8822
Inventor 郑恒丁玉峰冯湘玲曹艳刘义伟石友泉
Owner TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products